When I asked my cardiologist about these studies and Losartan in general, he made a candid admission that may help explain some of the confusion here: Often times, pharmaceutical companies want to push a certain drug and thus load a bunch of money behind it (both with studies like these and general marketing). He said it may end up to be true, however he sticks with betablockers because they have a long and proven history of harmlessly and effectively lowering blood pressure. The knowledge behind Losartan simply isn there yet .. It may come. His other point, which I'm sure we can all agree with, is one of timing. You can slow down aneurysms, but can't reverse them, so if you are at a dangerous point, all these drugs are simply to prevent immediate risk of dissection, not to "solve" the aneursym .. For younger patients, however, this may all bear fruit in the future. Speaking as a guy who had his 5.1 cm aneurysm operated on only three months after learning about it .. I wonder what the size would have been if it had been treated decades ago? Or is surgery inevitable?
My two cents.
